Canbreal Therodiagnostics International Inc.
This article was originally published in Start Up
Executive SummaryCanbreal Therodiagnostics is developing diagnostic kits that may help women gauge their risk of developing breast cancer. Analysis of two estrogen dependent cellular markers associated with increased cell division and a cancer's ability to metastasize may provide some quantitative measure of breast cancer risk
You may also be interested in...
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.